Cargando…
Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
BACKGROUND: Parkinson's disease (PD) is a neurodegenerative disorder with a significant immune component, as demonstrated by changes in immune biomarkers in patients' biofluids. However, which specific cells are responsible for those changes is unclear because most immune biomarkers can be...
Autores principales: | Nissen, Sara Konstantin, Ferreira, Sara Almeida, Nielsen, Marlene Christina, Schulte, Claudia, Shrivastava, Kalpana, Hennig, Dorle, Etzerodt, Anders, Graversen, Jonas Heilskov, Berg, Daniela, Maetzler, Walter, Panhelainen, Anne, Møller, Holger Jon, Brockmann, Kathrin, Romero‐Ramos, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247308/ https://www.ncbi.nlm.nih.gov/pubmed/33332647 http://dx.doi.org/10.1002/mds.28424 |
Ejemplares similares
-
Specific targeting of CD163(+) TAMs mobilizes inflammatory monocytes and promotes T cell–mediated tumor regression
por: Etzerodt, Anders, et al.
Publicado: (2019) -
Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017) -
Drug Trafficking into Macrophages via the Endocytotic Receptor CD163
por: Graversen, Jonas Heilskov, et al.
Publicado: (2015) -
Targeting of CD163(+) Macrophages in Inflammatory and Malignant Diseases
por: Skytthe, Maria K., et al.
Publicado: (2020) -
Targeting the Hemoglobin Scavenger receptor CD163 in Macrophages Highly Increases the Anti-inflammatory Potency of Dexamethasone
por: Graversen, Jonas H, et al.
Publicado: (2012)